Anavex Life Sciences Corp (AVXL)

[falconer66a]

Mitochondrial Disease Costs are Great

A new report tells of the profound problems and costs of mitochondrial diseases (such as Rett syndrome, for which Anavex will be testing its treatment in an upcoming clinical trial).

https://www.eurekalert.org/pub_releases/2017-06/chop-mdh062817.php

When patients with these diseases are hospitalized, they incur high medical costs, and suffer higher-than-typical rates of comorbid diseases and in-hospital mortality. Researchers who analyzed those costs using national databases say their findings underscore the importance of developing preventive strategies and therapies for these illnesses.

Anavex drugs correct mitochondrial dysfunctions, restore healthful cellular homeostasis.